Pfizer recalls all lots of anti-smoking drug over carcinogen presence

Send a link to a friend  Share

[September 17, 2021]  (Reuters) - Pfizer Inc said on Thursday it was recalling all lots of its anti-smoking treatment, Chantix, due to high levels of cancer-causing agents called nitrosamines in the pills.

The drugmaker paused distribution of the drug in June, and has already recalled a number of lots of the medicine so far.

Pfizer asked wholesalers and distributors on Thursday to stop the use and distribution of the tablets immediately.

The company said there was no immediate risk to patients

taking Chantix, but advised them to consult with their health care provider to check the availability of alternative treatments.

[to top of second column]

Chantix was approved by the FDA in May 2006 as a prescription medication to help adults aged 18 and over quit smoking and is typically used for 12 to 24 weeks.

(Reporting by Amruta Khandekar; Editing by Saumyadeb Chakrabarty)

[ 2021 Thomson Reuters. All rights reserved.]

Copyright 2021 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content

 

Back to top